XML 38 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Island Global Holdings, Inc.
New England Cannabis Corporation
Bloom Farms
Total 4Front Ventures Corp. Shareholders' Equity
Total 4Front Ventures Corp. Shareholders' Equity
Island Global Holdings, Inc.
Total 4Front Ventures Corp. Shareholders' Equity
New England Cannabis Corporation
Total 4Front Ventures Corp. Shareholders' Equity
Bloom Farms
Common Stock
Common Stock
Island Global Holdings, Inc.
Common Stock
New England Cannabis Corporation
Common Stock
Bloom Farms
Additional Paid-In Capital
Deficit
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2021                 594,181,604            
Beginning balance at Dec. 31, 2021 $ 37,532       $ 37,460       $ 274,120       $ 52,197 $ (288,857) $ 72
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Shares issued pursuant to acquisition (in shares)                   8,783,716 28,571,428 3,750,000      
Shares issued pursuant to acquisition   $ 6,245 $ 18,200 $ 2,100   $ 6,245 $ 18,200 $ 2,100   $ 6,245 $ 18,200 $ 2,100      
Shares issued to settle payables (in shares) 49,234,671                            
Warrants issued for Island pursuant to acquisition   732       $ 732       $ 732          
Share-based compensation (in shares)                 1,750,604            
Share-based compensation $ 7,214       7,214               7,214    
Conversion of notes to equity (in shares)                 6,235,512            
Conversion of notes to equity $ 3,122       3,122       $ 3,122            
Shares issued with exercise of stock options, (in shares) 133,333               51,975            
Shares issued with exercise of stock options $ 33       33       $ 33            
Shares issued with exercise of warrants (in shares)                 91,436            
Shares issued with exercise of warrants 50       50       $ 50            
Net loss $ (46,877) $ (10,986) $ (2,171)   (46,898)                 (46,898) 21
Ending balance (in shares) at Dec. 31, 2022 643,416,275               643,416,275            
Ending balance at Dec. 31, 2022 $ 28,351       28,258       $ 304,602       59,411 (335,755) 93
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Shares issued pursuant to acquisition (in shares)                 2,380,952            
Shares issued pursuant to acquisition $ 447       447       $ 447            
Shares issued to settle payables (in shares) 26,103,074               4,062,500            
Shares issued to settle payables $ 650       650       $ 650            
Share-based compensation 5,998       5,998               5,998    
Conversion of notes to equity (in shares)                 10,359,372            
Conversion of notes to equity $ 2,391       2,391       $ 2,391            
Shares issued with exercise of stock options, (in shares) 0                            
Shares issued for executive compensation (in shares)                 9,300,250            
Shares issued for executive compensation $ 862       862       $ 862            
Equity component of debt 1,333       1,333               1,333    
Warrants issued 206       206               206    
Net loss $ (91,632)       (91,647)                 (91,647) 15
Ending balance (in shares) at Dec. 31, 2023 669,519,349               669,519,349            
Ending balance at Dec. 31, 2023 $ (51,394)       $ (51,502)       $ 308,952       $ 66,948 $ (427,402) $ 108